Background: Permanent abnormalities have been reported in reproductive and non-reproductive organs of mice and humans exposed perinatally to a synthetic estrogen, diethylstilbestrol (DES). Recent studies demonstrated that sex hormones affected the shape of the innominate bone in mice. Therefore, we
Diethylstilbestrol effects and lymphomagenesis in Mlh1-deficient mice
β Scribed by Omar Kabbarah; Andrea K. Sotelo; Mary Ann Mallon; Erin L. Winkeler; Ming-Yu Fan; John D. Pfeifer; Darryl Shibata; David H. Gutmann; Paul J. Goodfellow
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- French
- Weight
- 217 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Inherited defects in DNA mismatch repair (MMR) predispose to a variety of malignancies in humans and in mouse knockout models. In humans, hemizygosity for one of several DNA MMR genes greatly increases an individual's risk for colon and endometrial carcinoma. Hemizygous mice develop gastrointestinal tumors at a low to moderate frequency. Homozygous nulls have higher rates of gastrointestinal tumors and are particularly susceptible to lymphoma. In an effort to model endometrial carcinoma associated with mutation in MMR, we treated mice carrying knockout alleles for Mlh1 or Msh2 with the synthetic estrogen diethylstilbestrol (DES), a known promoter of uterine endometrial carcinoma. The C57BL/6 mice carrying DNA MMR mutations failed to develop endometrial carcinomas. However, the Mlh1βdeficient mice treated with DES tended to become moribund at an early age and had very early onset of lymphoma. Comparison of DESβtreated and untreated Mlh1^β/β^ animals suggests the combination of Mlh1 deficiency and DES exposure accelerates lymphomagenesis. Β© 2005 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract To determine whether a constitutive __p53__ deficiency would enhance the rate of development of chemically induced hepatocellular carcinoma, we treated groups of wildβtype, __p53__βheterozygous (+/β), and null (β/β) male mice with a single dose of diethylnitrosamine at 12 d of age. Alth
C3HA and CBA female mice received a single intraperitoneal (i.p.) injection of 0.1 or 0.3 mg/kg body weight (b.w.) of diethylstilbestrol (DES) at day 17 of pregnancy. The descendants, starting from the age of 2-3 months, were receiving weekly subcutaneous (s.c.) injections of 1,2-dimethylhydrazine (